Background {#Sec1}
==========

The yeast *Saccharomyces cerevisiae* is used for the industrial production of fuel ethanol, the largest single product in industrial biotechnology. In comparison with ethanol, isobutanol has chemical properties that make it a superior fuel for several engine types \[[@CR1]\]. Moreover, isobutanol is an interesting precursor for a variety of products \[[@CR2]\]. While *S. cerevisiae* naturally produces isobutanol from sugars \[[@CR3], [@CR4]\], titres in wild-type cultures are very low. Its high glycolytic flux, ability to grow anaerobically and robustness in industrial processes (including its insensitivity to phage infection), has stimulated an intensive research effort in industry and academia to engineer this yeast for high-yield isobutanol production \[[@CR5]--[@CR12]\].

In *S. cerevisiae*, isobutanol is a natural product of valine catabolism via the Ehrlich pathway \[[@CR3], [@CR4]\]. In this pathway, valine is first transaminated to yield 3-methyl-2-oxobutanoate (α-ketoisovalerate, KIV), which is subsequently decarboxylated to isobutyraldehyde, whose NAD(P)H-dependent reduction by a yeast alcohol dehydrogenase yields isobutanol. Engineering *S. cerevisiae* for fast, efficient and anaerobic conversion of sugars into KIV, a natural intermediate of valine biosynthesis, involves major challenges, for example related to redox-cofactor balancing, subcellular compartmentation of key enzymes and iron-sulphur-cluster assembly in the Ilv3 protein \[[@CR6]\]. Perhaps because of the magnitude of these challenges, the subsequent step in isobutanol production, the decarboxylation of KIV, has received comparatively little attention in scientific literature.

*S. cerevisiae* contains four native thiamine-pyrophosphate-dependent 2-oxo acid decarboxylases, of which Pdc1, Pdc5 and Pdc6 encode pyruvate decarboxylase enzymes with a preference for linear-chain 2-oxo acids (pyruvate, 2-oxobutanoate and 2-oxopentanoate) \[[@CR13]\]. While the three Pdc isoenzymes exhibit a low activity with KIV, their much higher activity and affinity for pyruvate \[[@CR13]\] renders them unsuitable for high-efficiency production of isobutanol and other fusel alcohols. In contrast, Aro10 has been reported to have no activity with pyruvate and a much higher activity for the 2-oxo acid intermediates in fusel alcohol production \[[@CR14]\]. For example, Aro10 decarboxylates phenylpyruvate that is formed during phenylalanine degradation and plays a key role in yeast-based production of phenylethanol, an important aroma compound \[[@CR15]\]. However, *ARO10* is only transcribed during growth with aromatic, branched-chain or sulphur-containing amino acids as the nitrogen source \[[@CR16], [@CR17]\]. When ammonium sulphate is the nitrogen source, the wild-type *ARO10* gene is not transcribed and even the expression of *ARO10* from a constitutive promoter yields minimal enzyme activity indicating an as yet unknown mechanism of post-transcriptional regulation \[[@CR13], [@CR14]\].

Despite the low activity of Aro10 in cultures grown on simple nitrogen sources (such as urea and ammonium), constitutive overexpression of *ARO10*, combined with overexpression of valine biosynthesis genes has been used in metabolic engineering studies on isobutanol production by *S. cerevisiae* \[[@CR6], [@CR9]\]. Expression in *S. cerevisiae* of the *kivD* gene from *Lactococcus lactis* IFPL730, which encodes a 2-oxo acid decarboxylase, has also been used in several studies on isobutanol production \[[@CR7], [@CR8], [@CR10], [@CR11], [@CR18]\] and yielded higher isobutanol titres than expression of Aro10 \[[@CR10]\]. However, a quantitative comparison of these two decarboxylases is complicated by the simultaneous overexpression of other enzymes in the isobutanol pathway and by the presence of native 2-oxo acid decarboxylases (Pdc1, Pdc5, Pdc6, Aro10), and the use of complex media containing valine (a precursor for isobutanol production) and aromatic amino acids (which can induce *ARO10* activity).

KivD is not the only 2-oxo acid decarboxylase found in *L. lactis.* KdcA, identified in *L. lactis* B1157, has not yet been expressed in *S. cerevisiae* but has been used for engineering isobutanol production in *E. coli* \[[@CR19]\]. The genes (*kivD* vs *kdcA*) and proteins (KivD vs KdcA) exhibit 85 and 87 % identity at the DNA and protein level, respectively, suggesting that this enzyme may be a promising alternative in the context of isobutanol production. While a preliminary characterization of the substrate specificities of KivD and KdcA has been performed previously by expression in bacterial hosts \[[@CR18], [@CR20]\], a quantitative analysis of their performance after expression in *S. cerevisiae* is not available.

In view of the industrial relevance of yeast-based isobutanol production and the essential role of decarboxylation in this process, the goal of the present study is to evaluate the suitability of the 'novel' 2-oxo acid decarboxylase KdcA from *L. lactis* B1157 \[[@CR20]\], the frequently used KivD from *L. lactis* IFPL730 \[[@CR18]\], and the native *S. cerevisiae* 2-oxo acid decarboxylase Aro10 \[[@CR14]\] for metabolic engineering strategies aimed at constructing efficient isobutanol-producing *S. cerevisiae* strains. To this end, each 2-oxo acid decarboxylase was expressed from a strong constitutive promoter in a 'decarboxylase-negative' (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ, *aro10*Δ) *S. cerevisiae* strain background. However, pyruvate decarboxylase-negative (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ) strains (Pdc^−^) cannot grow on high glucose concentrations and also require C2-compounds (e.g. ethanol) for growth with low glucose concentrations. An evolutionary engineering strategy was used to identify a suppressor mutation to that phenotype \[[@CR21]\]. Therefore, to circumvent glucose sensitivity, a mutant allele of *MTH1* that encodes a negative regulator of the glucose-sensing signal transduction pathway which contains an 225 bp internal deletion was introduced to restore growth of the resulting Pdc^−^ strains on glucose \[[@CR21]\]. To evaluate and compare the three decarboxylases, an in vitro kinetic analysis was performed with a range of branched-chain and linear-chain 2-oxo acids. In vivo functionality was assessed by monitoring growth of 'single-decarboxylase' strains on several amino acids, whose catabolism proceeds via an Ehrlich pathway, as sole nitrogen sources. Finally, to test in vivo activity of the decarboxylases in isobutanol production, bioconversion of α-ketoisovalerate by the single-decarboxylase strains was studied in oxygen-limited cultures.

Results {#Sec2}
=======

In vitro enzymatic analysis of 2-oxo acid decarboxylase overexpression {#Sec3}
----------------------------------------------------------------------

The substrate specificity of the decarboxylases encoded by *kivD* and *kdcA* has been previously analysed using purified enzyme isolated from *L. lactis* IFPL730 (*kivD*) and using cell extracts via overexpression in *E. coli* (*kdcA*) \[[@CR18], [@CR20]\]. Despite their potential relevance for engineering of isobutanol-producing yeast, these enzymes have not previously been characterized upon expression in *S. cerevisiae*. We therefore compared their kinetic properties, not only for α-ketoisovalerate, but also for a wide range of branched-chain and linear-chain 2-oxo acids, with those of the native *S. cerevisiae* 2-oxo acid decarboxylase Aro10 in cell extracts of *S. cerevisiae* strains that expressed individual decarboxylase genes under the control of a strong, constitutive promoter.

The 'single-decarboxylase' *S. cerevisiae* strains IME260 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ *ARO10*↑), IME261 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ *kdcA*↑), IME262 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ *kivD*↑) and the decarboxylase-negative control strain IME259 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ p426GPD) were grown in 1-L shake flasks, containing 200 mL SME medium until mid-exponential phase (\~OD 4.0), followed by the preparation of cell extracts for enzyme activity assays. Ethanol was chosen as a carbon source to minimize risks of evolution of the decarboxylases towards the use of pyruvate as a substrate. Decarboxylase activity was assayed with, phenylpyruvate, α-ketoisovalerate, α-ketomethylvalerate, α-ketoisocaproate, 4-methylthio-2-oxobutanoate, 2-oxobutanoate, 2-oxopentanoate and pyruvate, 2-oxo acids intermediates of phenylalanine, valine, isoleucine, leucine, methionine, threonine, norvaline and ethanol metabolism, respectively. Decarboxylase activity was not observed for any of the substrates tested with cell extracts of strain IME260 (Aro10) or IME259 (decarboxylase-negative strain). These results confirm the earlier observation that Aro10 is not active in media containing ammonium sulphate as sole nitrogen source and that no other 2-oxo acid decarboxylases operate in strain IME259 \[[@CR13]\]. Kinetic parameters (*V*~max~ and *K*~m~) of KdcA (strain IME261) and KivD (strain IME262) were estimated by fitting kinetic data using non-linear regression of both the Michaelis--Menten and Hill equation. Clear Hill-type cooperativity was only observed for decarboxylation of KIV by KivD (Table [1](#Tab1){ref-type="table"}). In all other cases, estimated Hill coefficients were below 1.25 and, consequently, *V*~max~ and *K*~m~ values were calculated by fitting experimental data to the Michaelis--Menten equation.Table 1Decarboxylation kinetics of branched-chain, aromatic, sulphur-containing and linear 2-oxo acids by cell extracts of *S. cerevisiae* strains expressing single 2-oxo acid decarboxylase genesSubstrateStrain*K* ~m~ (mM)*V* ~max~ (U mg protein^−1^)Hill coefficient (n)*V* ~max~/*K* ~m~ (U mg protein^−1^ mM^−1^)PyruvateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)33.0 ± 3.610.03 ± 0.001.2 ± 0.40.00091IME262 (*kivD*↑)BDBDNANAPhenylpyruvateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)0.20 ± 0.040.12 ± 0.011.0 ± 0.10.60IME262 (*kivD*↑)BDBDNANAα-ketoisovalerateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)8.31 ± 1.342.34 ± 0.250.9 ± 0.10.28IME262 (*kivD*↑)7.73 ± 1.62^a^0.03 ± 0.00^a^2.70.0039α-ketomethylvalerateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)3.49 ± 0.340.69 ± 0.070.8 ± 0.10.20IME262 (*kivD*↑)12.9 ± 2.870.05 ± 0.011.00.0039α-ketoisocaproateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)0.57 ± 0.090.49 ± 0.001.00.86IME262 (*kivD*↑)2.42 ± 0.900.04 ± 0.011.20.0174-methylthio-2-oxobutanoateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)1.43 ± 0.220.13 ± 0.001.10.091IME262 (*kivD*↑)BD0.01 ± 0.00^b^NANA2-oxobutanoateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)5.58 ± 0.580.10 ± 0.011.10.018IME262 (*kivD*↑)BDBDNANA2-oxopentanoateIME259 (control)BDBDNANAIME260 (*ARO10*↑)BDBDNANAIME261 (*kdcA*↑)1.44 ± 0.280.17 ± 0.001.10.12IME262 (*kivD*↑)BDBDNANA*V* ~max~ and *K* ~m~ values were estimated from non-linear fitting of data to the Michaelis--Menten equation or, where indicated, the Hill equation. The Hill coefficient (*n*) was calculated from the Hill equation, with *n* \> 1 indicating positive cooperativity*NA* not applicable, *BD* below detection limit of 0.008 U mg protein^−1a^Calculated using the Hill equation^b^Enzyme activity at 25 mM substrate concentration

Cell extracts containing KivD (strain IME262) did not display a detectable activity with pyruvate. In contrast, cell extracts containing KdcA (strain IME261) exhibited a low but significant pyruvate decarboxylase activity. KivD exhibited similar maximum activities towards α-ketoisovalerate (*V*~max~ = 0.03 ± 0.00 U mg protein^−1^), α-ketomethylvalerate (*V*~max~ = 0.05 ± 0.01 U mg protein^−1^), α-ketoisocaproate (*V*~max~ = 0.04 ± 0.01 U mg protein^−1^), as well as a lower activity towards 4-methylthio-2-oxobutanoate (*V*~max~ = 0.01 ± 0.00 U mg protein^−1^) (Table [1](#Tab1){ref-type="table"}). Maximum activities of KdcA for these four substrates were an order of magnitude higher than those of KivD. *K*~m~ values of KivD and KdcA for α-ketoisovalerate were nearly identical, but KdcA showed a lower *K*~m~ towards the isoleucine and leucine-derived 2-oxo acids. While KdcA displayed the highest *V*~max~ with α-ketoisovalerate (2.34 ± 0.25 U mg protein^−1^), it also had a relatively high *K*~m~ (8.31 ± 1.34 mM) resulting in a lower overall affinity (*V*~max~/*K*~m~ = 0.28 U mg protein^−1^ mM^−1^). The highest affinity was observed for α-ketoisocaproate for both KdcA (*V*~max~/*K*~m~ = 0.86 U mg protein^−1^ mM^−1^) as well as KivD (*V*~max~/*K*~m~ = 0.017 U mg protein^−1^ mM^−1^). KdcA also displayed activity towards the linear-chain 2-oxo acids 2-oxopentanoate and 2-oxobutanoate (*V*~max~/*K*~m~ = 0.018 and 0.12 U mg protein^−1^ mM^−1^, respectively) while no activity with these substrates was found for KivD. These results indicate that, upon expression in yeast, KdcA has a much higher specific activity in cell extracts for α-ketoisovalerate, the key 2-oxo acid in isobutanol production, than KivD, as well as a broader substrate specificity.

2-oxo acid decarboxylase-dependent restoration of amino acid degradation {#Sec4}
------------------------------------------------------------------------

In *S. cerevisiae*, branched-chain and aromatic amino acid degradation is initiated by transamination. While the resulting 2-oxo acid cannot be assimilated, its irreversible decarboxylation generates a thermodynamic pull for transamination, while reduction or oxidation of the resulting aldehyde detoxifies it and facilitates its removal from the cell \[[@CR3]\]. When these amino acids are used as the nitrogen source, due to the deletion of native 2-oxo acid decarboxylases, the resulting 2-oxo acids may accumulate inside the cell leading to potential toxic effects and a negative impact on the thermodynamic feasibility of the transamination reactions \[[@CR3]\]. To test the ability of KdcA, KivD and Aro10 to function in vivo as the sole decarboxylase in amino acid degradation, aerobic specific growth rates in micro-titre plate of the decarboxylase-negative control strain IME259 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ, p426GPD), IME260 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ *ARO10*↑), IME261 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ *kdcA*↑) and IME262 (*pdc1*Δ *pdc5*Δ *pdc6*Δ *MTH1ΔTaro10*Δ *kivD*↑), as well as of decarboxylase-positive control IME140 (*PDC1PDC5PDC6ARO10* p426GPD) were measured in SMG medium containing 5 g/L of either valine, leucine, isoleucine, phenylalanine, methionine or (NH~4~)~2~SO~4~ as the sole nitrogen source.

Consistent with the presence of a full complement of native decarboxylases, IME140 displayed the highest specific growth rate on all nitrogen sources tested. The inability of the decarboxylase-negative strain IME259 to grow on valine, leucine or methionine as the sole nitrogen source confirmed the crucial role of 2-oxo acid decarboxylation in the catabolism of these amino acids. IME259 grew slowly on isoleucine and phenylalanine, indicating that *S. cerevisiae* can tolerate the build-up of the corresponding 2-oxo acids and/or efficiently export them from the cells. The reduced growth rate of strain IME259 on ammonium-containing medium can be attributed to the role of *PDC1*, *PDC5* and *PDC6* in the fast conversion of glucose via alcoholic fermentation and indicates that the role of 2-oxo acid decarboxylases is not limited to amino acid catabolism. Growth rates of all other strains were therefore normalized to that of the decarboxylase-positive reference strain IME140 (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Restoration of amino acid catabolism in native 'decarboxylase-negative' background by 2-oxo acid decarboxylase expression. Relative specific growth rates in micro-titre plate (µ~MTP~) of IME140 (*PDC1 PDC5 PDC6 ARO10*) (*white bars*), IME259 (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ, *aro10*Δ, *MTHΔT*, p426GPD) (*black bars*), IME260 (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ, *aro10*Δ, *MTHΔT*, *ARO10*↑) (*grey bars*), IME261 (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ, *aro10*Δ, *MTHΔT*, *kdcA*↑) (*blue bars*) and IME262 (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ, *aro10*Δ, *MTHΔT*, *kivD*↑) (*red bars*) in SMG supplemented with 5 g/L (NH~4~)~2~SO~4~ (NH~4~ ^+^), valine (Val), leucine (Leu), isoleucine (Ile), phenylalanine (Phe) and methionine (Met). Cells were grown aerobically in 500 µL volumes in 48-well plates and incubated at 30 °C with OD 660 measured at 15 min intervals. Data are presented as averages and standard deviations of duplicate experiments relative to the average specific growth rate in micro-titre plate of IME140 in each nitrogen source. Specific growth rates in micro-titre plate for IME140 on each nitrogen source were as follows; NH~4~ ^+^: 0.33 ± 0.01 h^−1^, Val: 0.24 ± 0.01 h^−1^, Leu: 0.16 ± 0.00 h^−1^, Ile: 0.14 ± 0.00 h^−1^, Phe: 0.19 ± 0.00 h^−1^, Met: 0.18 ± 0.00 h^−1^. NG: No Growth

Similar growth rates were obtained for the three single-decarboxylase strains when cultivated on ammonium sulphate. Expression of only Aro10 (strain IME260) stimulated growth only on phenylalanine (Fig. [1](#Fig1){ref-type="fig"}). This observation is consistent with a reported requirement for post-transcriptional regulation or activation by phenylalanine for its functional expression \[[@CR16]\]. IME261 (*kdcA*↑) and IME262 (*kivD*↑) grew on all nitrogen sources tested. Although KdcA showed substantially higher *V*~max~ values than KivD towards all substrates tested, the difference in growth rate between strains overexpressing these enzymes was less prominent. A better correlation was found between growth rates on the different branched-chain amino acids and the in vitro *V*~max~/*K*~m~ ratios for the corresponding 2-oxo acids (Table [1](#Tab1){ref-type="table"}). Growth studies and enzyme assays indicated that both *L. lactis* decarboxylases preferred α-ketoisocaproate (derived from leucine catabolism) over α-ketoisovalerate (derived from valine) and α-ketomethylvalerate (derived from isoleucine). While in vitro enzymatic activity of KivD for phenylpyruvate was below the detection limit of the assay, the comparatively high growth rate of IME262 on phenylalanine suggests that activity of KivD with this substrate may be higher in vivo.

Nitrogen source-dependent 2-oxo acid decarboxylase activity {#Sec5}
-----------------------------------------------------------

Expression of a gene from a constitutive promoter is not always sufficient to achieve high in vivo activity of the encoded protein. Earlier reports indicated that expression of Aro10 from a glycolytic promoter only yielded phenylpyruvate decarboxylase activity when *S. cerevisiae* was grown on phenylalanine \[[@CR14], [@CR16]\]. In the present study, phenylpyruvate decarboxylase activities in cell extracts of ammonium-grown cultures of the *kivD* overexpression strain IME262 were below detection limit, while its growth on phenylalanine was faster than on the other nitrogen sources tested. This observation prompted us to investigate whether phenylalanine-dependent decarboxylase activity also occurred for the *L. lactis* decarboxylases. Decarboxylation rates of pyruvate, phenylpyruvate and α-ketoisovalerate were measured in cell extracts of strains IME259 (control), IME260 (*ARO10*↑), IME261 (*kdcA*↑) and IME262 (*kivD*↑), grown on ammonium sulphate, phenylalanine or valine as sole nitrogen source (Table [2](#Tab2){ref-type="table"}). Due to the absence of 2-oxo acid decarboxylases, IME259 was unable to grow in medium containing valine or phenylalanine. Strain IME260 did not grow in valine medium, indicating that valine cannot activate Aro10 in the same way as phenylalanine. Strains IME261(*kdcA*↑) and IME262 (*kivD*↑) grew on all nitrogen sources, indicating that they encoded a functional 2-oxo acid decarboxylase activity irrespective of the nitrogen source.Table 22-oxo acid decarboxylase activities in cell extracts of *S. cerevisiae* strains expressing single 2-oxo acid decarboxylases, grown on different nitrogen sourcesSubstrateStrainNitrogen sourceNH~4~ ^+^PhenylalanineValinePyruvateIME259 (control)BDNGNGIME260 (*ARO10*↑)BDBDNGIME261 (*kdcA*↑)0.013 ± 0.0010.036 ± 0.0060.033 ± 0.005IME262 (*kivD*↑)BD0.012 ± 0.003BDPhenylpyruvateIME259 (control)BDNGNGIME260 (*ARO10*↑)BD0.046 ± 0.001NGIME261 (*kdcA*↑)0.045 ± 0.0080.184 ± 0.0290.155 ± 0.037IME262 (*kivD*↑)BD0.385 ± 0.0400.013 ± 0.000α-ketoisovalerateIME259 (control)BDNGNGIME260 (*ARO10*↑)BD0.056 ± 0.001NGIME261 (*kdcA*↑)0.683 ± 0.1462.509 ± 0.5091.900 ± 0.153IME262 (*kivD*↑)0.093 ± 0.0162.885 ± 0.1070.151 ± 0.030Enzyme activities, expressed as U mg protein^−1^, were determined at the following substrate concentrations: pyruvate: 50 mM, phenylpyruvate: 12.5 mM, α-ketoisovalerate: 25 mM*NG* no growth, *BD* below detection limit of 0.008 U mg protein^−1^

No decarboxylase activity was detected in cell extracts of strain IME259 (negative control) and of IME260 (*ARO10*↑) grown on ammonium sulphate (Table [2](#Tab2){ref-type="table"}). Cell extracts of strain IME260 grown on phenylalanine displayed decarboxylation activities with phenylpyruvate and α-ketoisovalerate, consistent with previous reports of phenylalanine-activated decarboxylase activity of Aro10 \[[@CR13], [@CR14]\]. Cell extracts of phenylalanine-grown cultures of the *kdcA* and *kivD* expressing strains IME261 and IME262 displayed a ca. threefold higher decarboxylase activity than ammonium sulphate grown cultures. In strain IME261 (*kdcA*↑), a similar high activity was found in cell extracts of valine-grown cultures. In contrast, cell extracts of valine-grown IME262 (*kivD*↑) showed no significant increase in activity relative to extracts of ammonium-grown cells.

In vivo α-ketoisovalerate bioconversion by 2-oxo acid decarboxylases {#Sec6}
--------------------------------------------------------------------

To further investigate the in vivo activity of the three decarboxylases in a context more akin to an engineered, isobutanol-producing strain, we incubated micro-aerobic cell suspensions of different decarboxylase-expressing strains in the presence of α-ketoisovalerate (KIV) and glucose. After conversion of KIV to isobutyraldehyde by the tested 2-oxo acid decarboxylases, isobutanol formation in these experiments relies on the multiple yeast alcohol dehydrogenases that can reduce isobutyraldehyde \[[@CR6]\]. Since many organic acids diffuse over the plasma membrane in their protonated form \[[@CR22]\] and considering the pKa of KIV (3.37), experiments were performed at pH 3.5 and at 6.0 to test the effect of both protonated and deprotonated KIV. In these experiments, the decarboxylase-negative strain IME259 did not produce detectable levels of isobutanol or ethanol. Strain IME140, which harbours a full complement of native yeast 2-oxo acid decarboxylases produced both ethanol and isobutanol (Table [3](#Tab3){ref-type="table"}). While pH had no significant impact on glucose consumption and ethanol production rates, KIV consumption and isobutanol production rates in all decarboxylase-expressing strains were at least twofold higher at pH 3.5 than at pH 6.0. In agreement with its high *V*~max~ in the in vitro enzyme activity measurements, IME261 (*kdcA*↑) exhibited the highest rate of isobutanol production, but also a higher ethanol production rate than strains IME260 (*ARO10*↑) and IME262 (*kivD*↑). This result is consistent with the pyruvate decarboxylase activity measured in vitro with KdcA (Table [1](#Tab1){ref-type="table"}). While in vitro enzymatic activities of Aro10 and KivD were below the detection limit, very low rates of ethanol formation observed for both strains in the KIV bioconversion experiments suggest that these enzymes may have a low activity with pyruvate. Based on the ethanol production rates, enzyme activities of 0.71 ± 0.3 mU mg protein^−1^ and 3.7 ± 0.1 mU mg protein^−1^ were estimated for IME260 (*ARO10*↑) and IME262 (*kivD*↑), respectively (data for pH 3.5, calculations based on cellular protein content of 42 % \[[@CR23]\]). These activities are below the detection limit of the enzyme assays (8 mU mg protein^−1^) while the estimated activity of KdcA was comparable to the in vitro value reported (8.1 ± 1.3 mU mg protein^−1^) (Table [4](#Tab4){ref-type="table"}). Estimated in vivo enzyme activities of KIV decarboxylation were much lower than the activities measured in vitro. This result suggests that, in all strains, isobutanol production might have been limited by KIV uptake.Table 3α-ketoisovalerate bioconversion under micro-aerobic conditions by *S. cerevisiae* strains expressing different 2-oxo acid decarboxylase genesStrainDecarboxylaseBiomass-specific production/consumption rates (mmol/g biomass/h)GlucoseEthanolKIVIsobutanolpH 6.0pH 3.5pH 6.0pH 3.5pH 6.0pH 3.5pH 6.0pH 3.5IME259None0.13 ± 0.010.15 ± 0.01BDBD0.01 ± 0.000.04 ± 0.00BDBDIME260*ARO10*↑0.16 ± 0.040.19 ± 0.000.02 ± 0.010.02 ± 0.010.04 ± 0.020.10 ± 0.000.04 ± 0.000.05 ± 0.00IME261*kdcA*↑0.35 ± 0.030.35 ± 0.000.24 ± 0.000.20 ± 0.030.07 ± 0.000.17 ± 0.000.05 ± 0.000.10 ± 0.00IME262*kivD*↑0.22 ± 0.010.22 ± 0.010.10 ± 0.010.10 ± 0.000.06 ± 0.010.12 ± 0.000.03 ± 0.000.07 ± 0.01IME140Wild-type control2.04 ± 0.251.71 ± 0.042.50 ± 0.052.86 ± 0.080.08 ± 0.010.26 ± 0.030.03 ± 0.010.10 ± 0.00Biomass-specific conversion rates were measured after addition of 10 g/L glucose and 100 mM α-ketoisovalerate (KIV) to cell suspensions at pH 6.0 and pH 3.5. Cells were incubated micro-aerobically (see "Methods") and incubated at 30 °C. Data are presented as averages and mean deviations of duplicate experiments*BD* below detection limit of HPLCTable 4Estimated in vivo activities of 2-oxo acid decarboxylases during α-ketoisovalerate (KIV) bioconversion experimentsStrainDecarboxylaseSubstratePyruvateKIVIME259NoneBDBDIME260*ARO10*↑0.71 ± 0.292.02 ± 0.02IME261*kdcA*↑8.07 ± 1.294.05 ± 0.05IME262*kivD*↑3.74 ± 0.072.81 ± 0.38IME140Wild-type control114 ± 33.83 ± 0.14Pyruvate and KIV decarboxylase activities were estimated from ethanol and isobutanol production rates at pH 3.5, based on a biomass protein content of 42 % \[[@CR23]\]. Activity is expressed in mU mg protein^−1^*BD* below detection limit of HPLC

Discussion {#Sec7}
==========

In metabolic engineering, knowledge on the kinetic properties and substrate specificity of (heterologous) enzymes used in product pathways is essential. For efficient isobutanol production by *S. cerevisiae* the 2-oxo acid decarboxylase should ideally combine: (1) high selectivity towards α-ketoisovalerate, which reduces competition for the active site and the formation of by-products (2) a high *V*~max~/*K*~m~ ratio, which enables fast conversion at low intracellular substrate concentrations, and in particular, (3) zero or very low activity with pyruvate, to prevent formation of ethanol as a major by-product. In this study, three 2-oxo acid decarboxylases that have previously been used in metabolic engineering of microbes for isobutanol production \[[@CR13], [@CR18], [@CR20]\] were evaluated based on these criteria. Our data on in vitro enzyme kinetics and substrate specificity are in good agreement with a recent characterization of *S. cerevisiae* Aro10 \[[@CR13]\]. They extend reports on the substrate specificity on KdcA and KivD expressed in the bacterial hosts *E. coli* and *L. lactis*, respectively, the data provided in this study showed similar substrate specificity trend for both KdcA and KivD \[[@CR18], [@CR20]\]. However, one notable deviation was the higher *K*~m~ of KivD for KIV observed in our results compared to previous reports (7.73 ± 1.62 mM vs. 1.9 mM). The difference in affinity might represent the difference in production host (*S. cerevisiae* vs *E. coli*) but also the sequence discrepancy since the purified enzyme from *E. coli* was also tagged with a N-terminus His~6~ tag.

The results show that while none of the three tested enzymes ideally met all three criteria, KdcA outperformed all other tested enzymes. KdcA displayed superior α-ketoisovalerate decarboxylase activity in in vitro assays (Table [1](#Tab1){ref-type="table"}), as well as in the in vivo KIV bioconversion experiments (Table [3](#Tab3){ref-type="table"}), but it also displayed the highest activity towards pyruvate, as illustrated by the in vivo KIV bioconversion experiments, this led to significant rates of ethanol production by a *kdcA* expressing strain. KivD displayed a lower activity towards pyruvate, but also supported lower rates of isobutanol production. Finally, Aro10 combined a very low activity for pyruvate with sub-optimal rates of KIV conversion and an, as yet unresolved, dependency on aromatic amino acids for full activity.

Our data indicate that, within this limited set of three decarboxylases, choice of an enzyme for isobutanol production in *S. cerevisiae* inevitably involves a compromise between KIV decarboxylation kinetics and formation of ethanol as a by-product. However, in view of the high *K*~m~ of KdcA for ethanol (33 ± 4 mM, Table [1](#Tab1){ref-type="table"}) it may also be possible to reduce ethanol production by preventing the occurrence of high intracellular pyruvate concentrations. The first step in the isobutanol product pathway is the conversion of pyruvate to acetolactate by acetolactate synthase (mitochondrial Ilv2 in wild-type *S. cerevisiae*). When the entire isobutanol pathway is expressed in the cytosol \[[@CR6]\], high-level expression of Ilv2 (*K*~m~ ca. 4 mM; \[[@CR24]\]) or of bacterial acetolactate synthases with lower *K*~m~ values \[[@CR25], [@CR26]\] may keep cytosolic pyruvate concentrations sufficiently low to curtail pyruvate decarboxylation via KdcA.

Hill cooperativity has been reported for Pdc1, Pdc5 and Pdc6 \[[@CR13], [@CR27], [@CR28]\] but not for Aro10 \[[@CR14]\]. In this study, Hill cooperativity was only observed for KivD and with KIV as the substrate. Whether this requirement for substrate binding in order to activate the enzyme represents a drawback of KivD depends on intracellular concentrations of KivD in engineered strains.

Our results show that, as previously reported for Aro10 \[[@CR14]\], expression from a constitutive promoter was not sufficient to achieve the highest activities of KivD and KdcA in media that contained ammonium sulphate as sole nitrogen source. KdcA activity was stimulated by growth with either valine or phenylalanine as the nitrogen source, while full activity of Aro10 and KivD activity was observed during growth on phenylalanine but not during growth on valine. The molecular mechanism for this post-transcriptional, nitrogen-source-dependent regulation has not yet been resolved. Understanding and, if possible, eliminating this level of regulation is a relevant goal in enabling robust, context-independent performance of decarboxylases in industrial isobutanol-producing strains.

While this study focused on the characterisation of 2-oxo acid decarboxylases potentially relevant for isobutanol production, the in vitro assays indicate that these enzymes may be applied in a wide range of alcohol production processes. In particular, KdcA displayed superior kinetic properties for a range of 2-oxo acids. Published studies on phenylethanol production \[[@CR15]\] and 1-butanol production \[[@CR12]\] use Aro10 and Pdc1, 5 and 6, respectively, to catalyse the decarboxylation of the relevant 2-oxo acid (phenylpyruvate and 2-oxopentanoate, respectively). However, this led either to a low activity (Aro10) or high rates of ethanol formation (Pdc1, 5 and 6). A comparison of data from the present study with a recent evaluation of the kinetics and substrate specificity of native *S. cerevisiae* decarboxylases \[[@CR13]\] reveals KdcA performs at least as well as the native *S. cerevisiae* 2-oxo acid decarboxylases for all non-pyruvate substrates tested. In particular, KdcA significantly outperforms all Pdc isoforms with 2-oxopentanoate as substrate (132-fold higher *V*~max~/*K*~m~ than for pyruvate, as compared to 1.2-fold for the best performing native decarboxylase Pdc5; \[[@CR13]\]). These data indicate that KdcA is an interesting enzyme for strategies to produce 1-butanol via the glyoxylate pathway \[[@CR12]\].

Thiamine-pyrophosphate-dependent decarboxylases are widespread in nature suggesting that while the present study failed to find an ideal candidate enzyme for isobutanol production, scanning biodiversity for novel enzymes may be useful to identify better performing candidates, in particular, identifying variants with lower specificity towards pyruvate. A BLAST search using Aro10, KdcA and KivD protein sequences yielded over 90 sequences with sequence identity above 35 % including enzymes derived from eukaryotic micro-organisms not known to produce isobutanol and more importantly ethanol \[[@CR29], [@CR30]\]. A future strategy to improve KIV decarboxylation in *S. cerevisiae* might therefore involve high-throughput screening of a diverse range of heterologous decarboxylases using the methods described in this study. For example, by measuring the degree of complementation of heterologous 2-oxo acid decarboxylases in the presence of both glucose (measuring pyruvate affinity) and valine (measuring KIV affinity), a large number of novel candidate enzymes could be rapidly evaluated. A further potential strategy might involve protein engineering (e.g. gene shuffling) approaches \[[@CR48]\]. In particular, future engineering should focus on optimizing *V*~max~ and *K*~m~ towards KIV, without a need for activation by specific amino acids and reducing the unwanted affinity towards pyruvate and other 2-oxo acids.

Conclusions {#Sec8}
===========

Analysis of three 2-oxo acid decarboxylases for isobutanol production in *S. cerevisiae* revealed that based on in vitro enzymatic data, and in vivo complementation and α-ketoisovalerate bioconversion, while no one enzyme ideally meets our criteria for an optimum 2-oxo acid decarboxylase, KdcA outperformed all other enzymes tested and should be investigated further for application in isobutanol and other higher alcohol production strategies.

Methods {#Sec9}
=======

Media, strains and maintenance {#Sec10}
------------------------------

All *S. cerevisiae* strains used in this study (Table [5](#Tab5){ref-type="table"}) were derived from the CEN.PK genetic background \[[@CR31], [@CR32]\]. Frozen stocks of *E. coli* and *S. cerevisiae* were prepared by addition of glycerol \[30 % (v/v)\] to exponentially growing cells and aseptically storing 1 mL aliquots at −80 °C. Cultures were grown in chemically defined medium containing either ammonium sulphate or various amino acids as sole nitrogen source. Ammonium sulphate medium contained 3 g/L KH~2~PO~4~, 0.5 g/L MgSO~4~∙7H~2~O and 5 g/L (NH~4~)~2~SO~4~ \[[@CR33]\]. Amino acid medium contained 6.6 g/L K~2~SO~4~, 3 g/L KH~2~PO~4~, 0.5 g/L MgSO~4~∙7 H~2~O and 5 g/L of the required amino acid. After supplementation of media with trace elements, vitamins and appropriate growth factors as described previously \[[@CR34]\], the pH was adjusted to 6.0. Chemically defined medium with glucose as sole carbon source (SMG) contained 20 g/L glucose and chemically defined medium with ethanol as sole carbon source (SME) contained 20 mL/L ethanol. If required, 150 mg/L uracil was added to the media in order to complement a uracil auxotrophy \[[@CR34]\]. For anaerobic growth Tween-80 (420 mg/L) and ergosterol (10 mg/L) were added. Defined medium plates were made with 20 g/L agar (Becton--Dickinson B.V. Breda, The Netherlands).Table 5*Saccharomyces cerevisiae* strains used in this studyStrainRelevant genotypeOriginIME140MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2* + p426GPD (2 µm *URA3*)\[[@CR31], [@CR49]\]CEN.PK707-4AMATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::loxP*\[[@CR13]\]IMI244MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::loxP MTH1∆T*This studyIMI271MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 ade2::PDC1_amdS*This studyIMI275MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::loxP MTH1∆T ade2::PDC1_amdS*This studyIMI302MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::cas*9-tagA-loxP-natNT2-loxP *MTH1∆T ade2::PDC1_amdS*This studyIMK647MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::cas9*-tagA-loxP-natNT2-loxP *MTH1∆T aro10Δ*This studyIME259MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::cas9*-tagA-loxP-natNT2-loxP *MTH1∆T aro10Δ* p426GPDThis studyIME260MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::cas9*-tagA-loxP-natNT2-loxP *MTH1∆T aro10Δ* pUDE001This studyIME261MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::cas9*-tagA-loxP-natNT2-loxP *MTH1∆T aro10Δ* pUDE321This studyIME262MATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1::loxP pdc5::loxP pdc6::cas9*-tagA-loxP-natNT2-loxP *MTH1∆T aro10Δ* pUDE336This studyCEN.PK113-7DMATa *URA3 HIS3 LEU2 TRP1 MAL2*-*8c SUC2*\[[@CR31], [@CR32]\]CEN.PK113-5DMATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2*\[[@CR31], [@CR32]\]TAMMATa *ura3*-*52 HIS3 LEU2 TRP1 MAL2*-*8c SUC2 pdc1Δ*::*loxP pdc5Δ*::*loxP pdc6Δ*::*loxP*, selected for C2 independence in glucose-limited chemostat cultures and glucose-tolerant growth in batch culture\[[@CR39]\]

Strain and plasmid construction {#Sec11}
-------------------------------

PCR amplification was performed using Phusion^®^ Hot Start II High Fidelity Polymerase (Thermo scientific, Waltham, MA) according to manufacturer's instructions using HPLC or PAGE purified, custom synthesized oligonucleotide primers (Sigma Aldrich, Zwijndrecht, The Netherlands) in a Biometra TGradient Thermocycler (Biometra, Göttingen, Germany). *L. lactis* B1157 *kdcA* \[AY548760.1\] and *L. lactis* IFPL730 *kivD* \[AJ746364.1\] open reading frames were codon optimized (co) for *S. cerevisiae* using the JCat algorithm \[[@CR35]\], synthesized and cloned into pMA vectors (Amp^R^) resulting in pUD342 and pUD350, respectively (GeneArt, Bleiswijk, The Netherlands; Table [6](#Tab6){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}). To construct the overexpression plasmids pUDE321 (*TDH3*~*P*~-co*kdcA*-*CYC1*~*t*~) and pUDE336 (*TDH3*~*P*~-co*kivD*-*CYC1*~*t*~), co-*kdcA* and co-*kivD* were PCR amplified from pUD342 and pUD350, respectively, with primer pairs "KdcA fwd GPD~P~ homology/KdcA rev CYC1~T~ homology" and "KivD fwd GPD~P~ homology/KivD rev CYC1~T~ homology" (Table [7](#Tab7){ref-type="table"}). The primers included a 5′ extension homologous to either the *TDH3* promoter or *CYC1* terminator regions of p426GPD \[[@CR36]\] to allow for Gibson assembly with the vector backbone \[[@CR37]\]. The p426GPD expression vector was digested with the restriction endonucleases SpeI and XhoI (Life Technologies Europe BV, Bleiswijk, The Netherlands), creating a linear vector backbone flanked by the *TDH3* promoter and *CYC1* terminator.Table 6Plasmids used in this studyNameCharacteristicsOriginpUD342*AmpR*, *E. coli* replicon, *COkdcA*This studypUD350*AmpR*, *E. coli* replicon, *COkivD*This studyp426GPD2 µm ori, *URA3*, *TDH3* ~*p*~-*CYC1* ~*t*~\[[@CR36]\]pUDE0012 µm ori, *URA3*, *TDH3p*-*ARO10*-*CYC1t*\[[@CR14]\]pUDE3212 µm ori, *URA3*, *TDH3p*-*kdcA*-*CYC1t*This studypUDE3362 µm ori, *URA3*, *TDH3p*-*kivD*-*CYC1t*This studypUG-AmdS2 µm ori, *URA3*, *TEF2p*-*amdS*-*TEF2t*\[[@CR40]\]pUG-natNT22 µm ori, *URA3*, *TEF2p*-*natNT2*-*TEF2t*\[[@CR45]\]p414-pTEF1-Cas9-tCYC12 µm ori, *URA3*, *TEF1p*-*cas9*-*CYC1t*\[[@CR44]\]pROS102 μm *URA3 gRNA*-*CAN1.Y gRNA*-*ADE2.Y*\[[@CR43]\]*CO* codon optimizedTable 7Oligonucleotide primers used in this studyNameSequence (5′ → 3′)Primers for CRISPR-Cas plasmid assembly Plasmid backbone amplificationGATCATTTATCTTTCACTGCGGAGAAG *ARO10* gRNA CRISPR KO sequenceTGCGCATGTTTCGGCGTTCGAAACTTCTCCGCAGTGAAAGATAAATGATCATTTACAAGTATTCTAAACCGTTTTAGAGCTAGAAATAGCAAGTTA\
AAATAAGGCTAGTCCGTTATCAAC *ARO10* repair fragment upperACAAGTTGACGCGACTTCTGTAAAGTTTATTTACAAGATAACAAAGAAACTCCCTTAAGCAAACTTGTGGGCGCAATTATAAAACACTGCTACCAA\
TTGTTCGTTTTCTGTTCATTAACA *ARO10* repair fragment lowerTGTTAATGAACAGAAAACGAACAATTGGTAGCAGTGTTTTATAATTGCGCCCACAAGTTTGCTTAAGGGAGTTTCTTTGTTATCTTGTAAATAAACT\
TTACAGAAGTCGCGTCAACTTGTPrimers for verification of knockouts PDC1 upstream fwdAGCTGTCCTCGTTGAACATAG PDC1 downstream revTTGCGTGAGGTTATGAGTAG PDC5 upstream fwdCAGAACCACCTACACTACC PDC5 downstream revCTGGGTTCTTAGCATCCTTG PDC6 upstream fwdAACTCCCGCAAACAAAGGTG PDC6 downstream revCAACACCTGCGAGATACCGTAG Aro10 upstream FwdTGCTTGTACACCTCATGTAG Aro10 downstream RevGCAGACATTTAGCAGATGTAGPrimers for verification of plasmid assembly and transformation GPD1 promoter FwdGGGATGTGCTGCAAGGCGATTAAGTTGG CYC1 terminator RevGGCAGTGAGCGCAACGCAATTAATGTGAGPrimers for verification of genome integrations MTH1ΔT conformation fwdCACCATGTTTGTTTCACCACCACCAGCAACTTCG MTH1ΔT conformation revTCAGGATACTGAATCCGGCTGCCAATCCA PDC1-AmdS at ADE2 conformation fwdATGTTATGCGCCTGCTAGAG PDC1-AmdS at ADE2 conformation revACATTCCGCCATACTGGAGG Cas9-tag-natNT2 at PDC6 conformation fwdAACTCCCGCAAACAAAGGTG Cas9-tag-natNT2 at PDC6 conformation revCAACACCTGCGAGATACCGTAGPrimers for plasmid construction KdcA fwd GPD~P~ homologyCTACTTTTATAGTTAGTCTTTTTTTTAGTTTTAAAACACCAGAACTTAGTTTCGACGGATATGGATACAGTAGGAGATTACCTGTTAGACCG KdcA rev CYC1~T~ homologyCGGTTAGAGCGGATGTGGGGGGAGGGCGTGAATGTAAGCGTGACATAACTAATTACATGACTATTTATTTTGCTCAGCAAATAATTTACCC KivD fwd GPD~P~ homologyCTACTTTTATAGTTAGTCTTTTTTTTAGTTTTAAAACACCAGAACTTAGTTTCGACGGATATGTACACTGTTGGTGACTAC KivD rev CYC1~T~ homologyCGGTTAGAGCGGATGTGGGGGGAGGGCGTGAATGTAAGCGTGACATAACTAATTACATGATTAAGACTTGTTTTGTTCAGCGAACAACTTACCCPrimers for cassette construction MTH1ΔT fwdCACCATGTTTGTTTCACCACCACCAGCAACTTCG MTH1ΔT revTCAGGATACTGAATCCGGCTGCCAATCCA PDC1-ADE2 homology fwdTTGCCCCAAGGCCTCACAACTCTGGACATTATACCATTGATGCTTGCGTCACTTCTCAATTTGAAGCTCATTTGAGATCAATATTGGATTTGCCAA\
TGCCTGCGACTGGGTGAGCATATG PDC1-TEF2~T~ homology revCAGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTGATCGGTTTTTTTTTTGGAAGACATCTTTTCC AmdS cassette fwdCAGTATAGCGACCAGCATTC AmdS-ADE2 homology revGGCATTGGCAAATCCAATATTGATCTCAAATGAGCTTCAAATTGAGAAGTGACGCAAGCATCAATGGTATAATGTCCAGAGTTGTGAGGCCTTG\
GGGCAAGACATGGAGGCCCAGAATAC PDC1-AmdS-ADE2 homology fwdTCTAAGTACATCCTACTATAACAATC PDC1-AmdS-ADE2 homology revCATTTGATGTAATCATAACAAAGCC Cas9-PDC6 homology fwdGTGCCTATTGATGATCTGGCGGAATGTCTGCCGTGCCATAGCCATGCCTTCACATATAGTCCGCAAATTAAAGCCTTCGAG Cas9-tag homology revGCAGTCCTCTTTTATATACAGTATAAATAAAAAACCAGTAATATAGCAAAAACATATTGCCAGGGAACAAAAGCTGGAGCTCATAG natNT2-tag homology fwdGTGCCTATTGATGATCTGGCGGAATGTCTGCCGTGCCATAGCCATGCCTTCACATATAGTCCGCAAATTAAAGCCTTCGAG natNT2-PDC6 homology revCAAACTGTGTAAATTTATTTATTTGCAACAATAATTCGTTTTTGAGTACACTACTAATGGCATAGGCCACTAGTGGATCTG

The expression vectors were assembled using Gibson assembly^®^ Master Mix (NEB, Ipswich, MA, USA) according to the manufacturer's instructions. The assembly mix was then transformed into chemically competent *E. coli* (T3001, Zymo research, Irvine, CA, USA) according to the manufacturer's instructions, and the gene sequences were confirmed by Sanger sequencing (BaseClear, Leiden, The Netherlands).

The 2-oxo acid decarboxylase-negative background strain IMK647 (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ, *aro10*Δ *MTH1ΔT*) was constructed by first introducing the *MTH1ΔT* allele which restores growth on glucose \[[@CR21]\] into CEN.PK707-4A (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ) \[[@CR13]\] using the pop in/pop out method \[[@CR38]\]. This resulted in strain IMI244. The *MTH1ΔT* integration fragment was generated by PCR using genomic DNA of the *S. cerevisiae* TAM strain as a template \[[@CR21], [@CR39]\]. Subsequent DNA editing in this Pdc^−^ background proved difficult. To facilitate subsequent modifications, the *PDC1* gene was re-introduced in a manner which allowed its rapid excision. The *PDC1* gene (including native promoter and terminator) was amplified from CEN.PK113-7D using primers with added homology to the coding region of the *ADE2* locus and the *TEF2* terminator region of the *amdS* cassette. The *amdS* gene cassette was amplified in a similar manner from pUG-AmdSYM \[[@CR40]\] using primers with added homology to the target region of the *ADE2* locus. Transformation of both fragments into CEN.PK113-5D resulted in simultaneous assembly and integration of both cassettes at the *ADE2* locus. Correct integrants were selected by plating transformants on medium containing 0.6 g/L acetamide as the sole nitrogen source \[[@CR40]\], 20 mg/L adenine to relieve the auxotrophy caused by *ADE2* disruption (which allowed for detection of integrants by their red colony colour) \[[@CR41]\], and 0.15 g/L uracil to complement the uracil auxotrophy. This resulted in strain IMI271. While integration of the *PDC1*-*amdS* cassette interrupted the *ADE2* gene, its full sequence information was retained in the genome. A functional *ADE2* gene and adenine prototrophy could therefore be restored by excision of the cassette (\[[@CR42]\], Fig. [2](#Fig2){ref-type="fig"}b). The integrated cassette was then used as PCR template to generate a full *PDC1*-*amdS* integration cassette at the *ADE2* locus, the resulting cassette was then transformed into IMI244 (*pdc1*Δ, *pdc5*Δ, *pdc6*Δ *MTH1ΔT*), using the selection procedure described above, resulting in strain IMI275. To allow for subsequent rapid deletions in this strain background, the CRISPR-Cas gene editing system was introduced \[[@CR43]\]. A *cas9*-natNT2 gene cassette was generated by amplifying the *cas9* overexpression cassette from p414-pTEF1-*cas9*-tCYC \[[@CR44]\] using primers with added homology to the upstream region of the *PDC6* locus and a unique 60 bp tag (Cas9-PDC6 homology fwd/Cas9-tag homology rev). Similarly, the natNT2 expression cassette was amplified from pUG-natNT2 \[[@CR45]\] using primers with added homology to the downstream region of the *PDC6* locus and the same unique 60 bp tag (natNT2-tag homology fwd/natNT2-PDC6 homology rev) (Table [7](#Tab7){ref-type="table"}). After transformation of both fragments, selection on agar medium containing 100 mg/L nourseothricin (Jena Bioscience, Jena, Germany), yielded strain IMI302. Finally, the decarboxylase-negative strain IMK647 was constructed by removing the *ARO10* gene using the introduced Cas9 system. Assembly of a plasmid containing the *ARO10*-specific guide RNA and subsequent Cas9-mediated removal of the *ARO10* gene were achieved in a single in vivo homologous recombination reaction step \[[@CR43]\]. In this step, transformation of the CRISPR plasmid backbone (amplified from pROS10), the *ARO10* specific guide RNA fragment and the single-stranded *ARO10* repair fragments resulted in in vivo assembly of the plasmid, a Cas9-mediated double-strand break in the *ARO10* gene, and repair of that break using a repair fragment with homology to the upstream and downstream regions of *ARO10*. Transformants were selected on SMG plates supplemented with 20 mg/L adenine. A transformant with the correct genotype was then restreaked three times on plates containing 2.3 g/L fluoroacetamine, 1 g/L 5-fluoorotic acid (5′FOA), 0.150 g/L uracil, and the absence of adenine to induce the simultaneous loss of the in vivo assembled plasmid containing the *ARO10*-specific guide RNA and the *PDC1*-*amdS* cassette (Fig. [2](#Fig2){ref-type="fig"}b) resulting in strain IMK647.Fig. 2Overview of strain construction genealogy used in this study and transient *PDC1*-*amdS* expression cassette for targeted integration and rapid excision at the *ADE2* locus. **a** The order in which strains were constructed, as well as the modifications made either by (1) targeted integration of PCR product, (2) removal of gene or transient gene cassette or (3) introduction of a gene encoding plasmid. **b** The transient *PDC1* and *amdS* expression cassettes containing homology to the other respective cassette and to the *ADE2* locus were transformed into IMI244 allowing homologous assembly into a full-length cassette and targeted integration at the *ADE2* locus when plated on selective media containing acetamide (0.6 g/L) and adenine (20 mg/L) (resulting in IMI275). The resulting integration cassette was flanked by identical tags which have homology to the *ADE2* locus such that when plated on selective media containing fluoroacetamide (2.3 g/L) and the absence of adenine, removal of the cassette was induced resulting in reassembly of a functional *ADE2* gene (resulting in IMK647)

The 2-oxo-acid decarboxylase overexpression strains, as well as the prototrophic 2-oxo acid decarboxylase minus empty vector control were constructed by transforming IMK647 with plasmids p426GPD (empty vector), pUDE001 (*ARO10*), pUDE321 (*kdcA*) and pUDE336 (*kivD*), resulting in strains IME259 (p426GPD), IME260 (*ARO10*), IME261 (*kdcA*) and IME262 (*kivD*). An overview of the different steps in the construction of these strains and the use of the removable *PDC1*-*amdS* cassette is presented in Fig. [2](#Fig2){ref-type="fig"}. After propagation in *E. coli*, plasmids were isolated with the Sigma GenElute Plasmid kit (Sigma Aldrich). In all cases yeast transformants were selected on SME agar.

*Saccharomyces cerevisiae* transformation was performed by the lithium acetate method \[[@CR46]\]. Correct assembly of plasmids and chromosomal integration constructs were checked by diagnostic PCR with specific primer sets (Table [7](#Tab7){ref-type="table"}), using DreamTaq polymerase (Thermo scientific) and desalted primers (Sigma Aldrich).

Shake flask cultivation {#Sec12}
-----------------------

All *S. cerevisiae* strains were grown in chemically defined medium as described above. Strains were grown in either 1-L or 500-mL shake flasks containing 200 or 100 mL synthetic medium, respectively, at 30 °C in an Innova incubator (New Brunswick Scientific, Edison, NJ) set at 200 rpm. Optical density at 660 nm was measured using a Libra S11 spectrophotometer (Biochrom, Cambridge, UK).

In vitro enzymatic analysis of 2-oxo acid decarboxylase overexpression {#Sec13}
----------------------------------------------------------------------

Determination of *K*~m~ and *V*~max~ of 2-oxo acid decarboxylases was determined in an enzyme assay in which the activity of a 2-oxo acid decarboxylase was coupled to the conversion of an aldehyde to its corresponding acid by purified *S. cerevisiae* aldehyde dehydrogenase \[[@CR13]\]. NAD^+^ reduction was monitored spectrophotometrically at 340 nm. Assays were performed at 30 °C in a Hitachi U-3010 spectrophotometer. Cell extracts were prepared by harvesting 62.5 mg of biomass by centrifugation at 4600×*g* for 5 min. Cell pellets were washed with 10 mM potassium phosphate buffer containing 2 mM EDTA at pH 7.5, then washed again and resuspended in 100 mM potassium phosphate buffer at pH 7.5 containing 2 mM MgCl~2~ and 2 mM dithiothreitol (DTT). Extracts were prepared using Fast Prep FP120 (Thermo Scientific) with 0.7-mm glass beads. Cells were disintegrated in four bursts of 20 s with 30 s of cooling on ice between runs. Cellular debris was removed by centrifugation at 47,000*g* for 20 min at 4 °C \[[@CR47]\]. The cell extract was then used immediately for enzyme assays. Protein concentrations in cell extracts were determined with the Lowry method \[[@CR48]\].

The 1 mL assay mixture for measuring 2-oxo acid decarboxylase activity contained 100 mM potassium phosphate buffer (pH 7.0), 0.2 mM thiamine pyrophosphate, 5 mM MgCl~2~, 15 mM pyrazole, 2 mM NAD^+^ and 1.75 U/mL aldehyde dehydrogenase and between 5 and 100 µL of cell extract. The reaction was initiated by addition of a 2-oxo acid. Reaction rates were linearly proportional to the amount of cell extract added. Enzyme activities were assayed at substrate concentrations ranging from 0 to 12.5 mM for phenylpyruvate, 0--100 mM for pyruvate, and 0--50 mM for α-ketoisovalerate, α-ketomethyvalerate, α-ketoisocaproate, 4-methylthio-2-oxobutanoate, 2-oxobutanoate and 2-oxopentanoate. K~m~ and V~max~ were estimated by fitting kinetic data from at least six different substrate concentrations with GraphPad Prism 4.0 (GraphPad Software, Inc, La Jolla, CA) using non-linear regression of the Michaelis--Menten and Hill equations.

2-oxo acid decarboxylase-dependent restoration of amino acid catabolism {#Sec14}
-----------------------------------------------------------------------

Restoration of amino acid catabolism by various 2-oxo acid decarboxylases was tested by measuring the specific growth rate in micro-titre plate (µ~MTP~) of strains incubated aerobically in 48-well plates (Greiner Bio-One, Alphen aan Den Rijn, The Netherlands) with different amino acids as sole nitrogen source. Cells were pre-cultured in 100 mL SME medium containing 0.2 mM (NH~4~)~2~SO~4~. Precultures were grown until the residual ammonium was depleted. Cells were then washed twice in nitrogen- and carbon-source-free synthetic medium, and inoculated in wells to an initial OD 660 of 0.01. Each well contained 500 µL SMG medium supplemented with 5 g/L of either valine, leucine, isoleucine, phenylalanine, methionine or (NH~4~)~2~SO~4~. The 48-well plates were incubated aerobically at 30 °C in a GENios pro plate reader (Tecan Benelux, Giessen, The Netherlands), under constant shaking at 200 rpm. OD 660 was measured automatically at 15 min intervals.

In vivo α-ketoisovalerate bioconversion by 2-oxo acid decarboxylases {#Sec15}
--------------------------------------------------------------------

The in vivo activity and affinity of each 2-oxo acid decarboxylase towards α-ketoisovalerate (KIV) was assessed by measuring the production of isobutanol in micro-aerobic high-cell-density cultures supplemented with high concentrations of KIV. To this end, each strain was pregrown in 200 mL SME medium until mid-exponential phase (\~OD 4.0), cells were centrifuged 4700*g* for 5 min and resuspended to a final OD 660 of \~40.0 in 25 mL synthetic medium supplemented with 10 g/L glucose Tween-80 (420 mg/L), ergosterol (10 mg/L) and 100 mM KIV. The initial pH was set to 3.5 or 6.0 by addition of 2 M H~2~SO~4~ or 2 M KOH. Cultures were then incubated at 30 °C in 30 mL rubber-stoppered serum bottles to create micro-aerobic conditions. Each rubber stopper was pierced with a 0.6 mm, Microlance needle (Becton--Dickinson, Breda, The Netherlands), fitted with a cotton-wool plugged syringe cylinder to prevent pressure build-up. Samples were taken to determine extracellular metabolite concentrations, OD 660 and pH over the linear phase of glucose consumption. To limit introduction of oxygen, samples were taken by attaching a sterile syringe to the needle, inverting the serum bottle and withdrawing \~200 µL culture liquid. To determine extracellular glucose, ethanol, KIV (α-ketoisovalerate) and isobutanol concentrations culture samples were spun down at 3500 g and the supernatant was collected. Extracellular metabolites were analysed using an Agilent 1260 Affinity HPLC machine (Agilent Technologies, Amstelveen, The Netherlands) with an Aminex HPX-87H ion-exchange column (BioRad) operated at 60 °C with a mobile phase of 5 mM H~2~SO~4~ and a flow rate of 0.6 mL/min. Biomass concentrations were estimated from OD 660 measurements, assuming that 1 g/L of cell biomass corresponds to an OD 660 value of 4.02.

Additional file {#Sec16}
===============

10.1186/s13068-015-0374-0 Sequence of the expression cassettes of the yeast codon optimised kdcA and kivdD genes.

KIV

:   α-ketoisovalerate

Pdc

:   pyruvate decarboxylase

Pdc^−^

:   pyruvate decarboxylase negative

OD

:   optical density

SMG

:   chemically defined (synthetic) medium glucose

SME

:   chemically defined (synthetic) medium ethanol

BLAST

:   Basic Local Alignment Search Tool

5'FOA

:   5-fluoorotic acid

DTT

:   dithiothreitol

Val

:   valine

Ile

:   isoleucine

Leu

:   leucine

Met

:   methionine
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